Rozencweig M - Search Results

1

Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).

Holdener EE, Hansen HH, Høst H, Bruntsch U, Cavalli F, Renard J, Pinedo HM, Rozencweig M. Holdener EE, et al. Among authors: rozencweig m. Invest New Drugs. 1985;3(1):63-6. doi: 10.1007/BF00176826. Invest New Drugs. 1985. PMID: 3857219

2

Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.

Joss RA, Hansen HH, Hansen M, Renard J, Rozencweig M. Joss RA, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1984 Apr;20(4):495-9. doi: 10.1016/0277-5379(84)90234-7. Eur J Cancer Clin Oncol. 1984. PMID: 6327315

3

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.

Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G. Rozencweig M, et al. J Clin Oncol. 1984 Apr;2(4):275-81. doi: 10.1200/JCO.1984.2.4.275. J Clin Oncol. 1984. PMID: 6584561 Clinical Trial.

4

Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.

Høst H, Joss R, Pinedo H, Bruntsch U, Cavalli F, Renard G, van Glabbeke M, Rozencweig M. Høst H, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1983 Feb;19(2):295-8. doi: 10.1016/0277-5379(83)90430-3. Eur J Cancer Clin Oncol. 1983. PMID: 6681775

5

Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.

De Jager R, Siegenthaler P, Cavalli F, Klepp O, Bramwell V, Joss R, Alberto P, van Glabbeke M, Renard J, Rozencweig M, Hansen HH. De Jager R, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1983 Feb;19(2):289-93. doi: 10.1016/0277-5379(83)90429-7. Eur J Cancer Clin Oncol. 1983. PMID: 6687457

6

Phase II study of 9-hydroxy-2N-methylellipticinium acetate.

Clarysse A, Brugarolas A, Siegenthaler P, Abele R, Cavalli F, de Jager R, Renard G, Rozencweig M, Hansen HH. Clarysse A, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1984 Feb;20(2):243-7. doi: 10.1016/0277-5379(84)90190-1. Eur J Cancer Clin Oncol. 1984. PMID: 6538489

7

Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma.

Alberto P, Rozencweig M, Clavel M, Siegenthaler P, Cavalli F, Gundersen S, Bruntsch U, Renard J, Pinedo H. Alberto P, et al. Among authors: rozencweig m. Cancer Chemother Pharmacol. 1986;16(1):78-9. doi: 10.1007/BF00255292. Cancer Chemother Pharmacol. 1986. PMID: 2933177

8

Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.

Mulder JH, Dodion P, Cavalli F, Czarnetzki B, Clavel M, Thomas D, Suciu S, Rozencweig M. Mulder JH, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1297-301. doi: 10.1016/0277-5379(82)90132-8. Eur J Cancer Clin Oncol. 1982. PMID: 6891928

9

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck.

Rozencweig M, Dodion P, Bruntsch U, Gallmeier W, Clavel M, Gignoux B, Cortes Funes H, Cavalli F, Kirkpatrick A, Dalesio O, et al. Rozencweig M, et al. Cancer. 1984 Oct 15;54(8):1499-503. doi: 10.1002/1097-0142(19841015)54:8<1499::aid-cncr2820540804>3.0.co;2-t. Cancer. 1984. PMID: 6206936 Clinical Trial.

10

Phase II study of oral VP-16-213 in hepatocellular carcinoma.

Cavalli F, Rozencweig M, Renard J, Goldhirsch A, Hansen HH. Cavalli F, et al. Among authors: rozencweig m. Eur J Cancer Clin Oncol. 1981 Oct;17(10):1079-82. doi: 10.1016/0014-2964(81)90291-7. Eur J Cancer Clin Oncol. 1981. PMID: 6279406 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters